Skip to main content
Premium Trial:

Request an Annual Quote

UK Grants Nearly $6M for North/East England High-throughput Hubs

NEW YORK (GenomeWeb News) — The United Kingdom has granted a total of £3.9 million ($5.8 million) to the University of Liverpool and to the Babraham Institute to start two high-throughput genomics hubs as part of a three-prong program to enhance the country's DNA sequencing resources.

The University of Liverpool will use £2.2 million ($3.3 million) from the Medical Research Council (MRC) and the Northwest Regional Development Agency to establish a high-throughput genomic analysis hub in the North of England as part of an effort to increase the nation's genomics resources and to advance academic medical science, the university said today.

£2 million came from the MRC and £200,000 came from the Northwest Regional Development Agency. The initiative is part of a £7 million effort to support hubs in North and East England, and in Scotland.

These high-throughput centers will be available for use by all academic researchers in the UK.

This Northern hub will consolidate resources from four partner universities: Manchester, Sheffield, Lancaster, and Liverpool.

Supported in part by the Clatterbridge Cancer Research Trust, this hub will conduct tumor sequencing studies, and will pursue research into genetic susceptibility and personalized medicine.

In a separate announcement, the Babraham Institute said today that it is using its £1.65 million ($2.5 million) grant to start a genome sequencing facility through a partnership with the University of Cambridge's Centre for Trophoblast Research. Funding for this center came from MRC and from the Biotechnology and Biological Sciences Research Council.

"There is a pressing need to understand the basis of genetic variation and to use it to define the most appropriate treatment for each patient with a particular condition," Professor Neil Hall, of the School of Biological Sciences and a principal investigator at the North of England hub, said in a statement. "Such research will benefit greatly from the new hub in the North of England by allowing much more productive sequencing technologies to be made available across the research community."

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.